查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1503262

細胞與基因治療藥物冷鏈物流市場：2024-2034

Cell & Gene Therapy Cold Chain Logistics Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 359 Pages | 商品交期: 最快1-2個工作天內

價格

到2034年，細胞和基因治療藥物的全球冷鏈物流市場預計將以 15.5%的年複合成長率成長。

高癌症發生率推動了細胞和基因療法的採用：

過去十年，全球癌症發生率增加，大大影響了細胞和基因療法等先進治療方法的採用。這種增加包括多種癌症，如淋巴瘤、白血病、骨髓瘤和黑色素瘤，它們影響重要的身體系統，如淋巴系統、淋巴結、骨髓和血球。PAHO/WHO報告指出，2023年將出現約 2,000 萬新癌症病例。據預測，全球受癌症影響的人數大幅增加，預計到2040年將超過 2800 萬人。在美國，僅非何杰金氏淋巴瘤就佔所有癌症患者的 4%以上，使其成為最常見的癌症之一。這些統計資料凸顯了對創新治療的迫切需求。隨著顯著的成功和監管部門的批准，細胞和基因療法越來越被視為解決世界各地癌症患者未滿足的醫療需求的必要條件。

發展中國家冷鏈物流基礎設施不足可能對成長構成挑戰：

在發展中國家和偏遠地區，由於冷鏈物流基礎設施不足，獲得細胞和基因治療的機會受到嚴重限制。由於電源不可靠，冷卻通常不可靠，增加了產品變質的風險。這些地區的交通基礎設施也帶來了重大挑戰，使治療藥物的及時交付變得複雜和延遲。克服這些物流障礙需要與當地物流提供者（例如非洲Riders for Health）建立策略合作夥伴關係，以確保有效的分銷網絡。

本報告調查了細胞和基因療法藥物的全球冷鏈物流市場，提供了市場概況，影響市場成長和市場機會的因素、法律和監管環境、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、競爭狀況和主要公司概況的分析。

目錄

第1章 報告概述

第2章 執行摘要

第3章 市場概述

  • 主要發現
  • 市場動態
  • 影響分析
    • 市場驅動因素
    • 市場限制因素
    • 市場機會
  • 監理框架
  • 新興市場與大趨勢
  • 波特五力分析
  • PEST分析

第4章 細胞與基因治療藥物冷鏈物流市場分析：依組成部分

  • 主要調查結果
  • 市場吸引力指數
  • 市場規模趨勢與預測
  • 低溫托運容器
  • 低溫冷凍櫃
  • 超低溫冷凍櫃
  • 冷鏈管理系統
  • 傳送/儲存媒體
  • 低溫包裝套件
  • 其他
    • 市場規模趨勢與預測：依地區劃分
    • 市佔率：依地區劃分

第5章 細胞及基因治療藥物冷鏈物流市場分析：依服務劃分

  • 主要調查結果
  • 市場吸引力指數
  • 市場規模趨勢與預測
  • 交通
  • 儲存
  • 包裝
    • 市場規模趨勢與預測：依地區劃分
    • 市佔率：依地區劃分

第6章 細胞及基因治療藥物冷鏈物流市場分析：以運輸方式劃分

  • 主要調查結果
  • 市場吸引力指數
  • 市場規模趨勢與預測
  • 航空運輸
  • 陸上交通
  • 水路運輸
    • 市場規模趨勢與預測：依地區劃分
    • 市佔率：依地區劃分

第7章 細胞及基因治療藥物冷鏈物流市場分析：依儲存溫度劃分

  • 主要調查結果
  • 市場吸引力指數
  • 市場規模趨勢與預測
  • 低溫
  • 冷藏
  • 環境溫度
  • 其他
    • 市場規模趨勢與預測：依地區劃分
    • 市佔率：依地區劃分

第8章 細胞與基因治療藥物冷鏈物流市場分析：依最終使用者劃分

  • 主要調查結果
  • 市場吸引力指數
  • 市場規模趨勢與預測
  • 生物製藥和生物技術公司
  • 學術研究所
  • 其他
    • 市場規模趨勢與預測：依地區劃分
    • 市佔率：依地區劃分

第9章 細胞及基因治療藥物冷鏈物流市場分析：依地區

  • 主要調查結果
  • 市場規模趨勢與預測

第10章 北美細胞及基因治療藥物冷鏈物流市場分析

第11章 歐洲細胞與基因治療藥物冷鏈物流市場分析

第12章 亞洲細胞與基因治療藥物冷鏈物流市場分析

第13章 拉丁美洲細胞與基因治療藥物冷鏈物流市場分析

第14章 中東與非洲細胞與基因治療藥物冷鏈物流市場分析

第15章 公司簡介

  • 公司佔有率分析
  • 戰略展望
  • Cencora, Inc.
  • Arvato SE
  • Polar Express Transportation
  • NMDP BioTherapies
  • BioLife Solutions, Inc.
  • Cardinal Health
  • Catalent, Inc.
  • Cryoport Inc.
  • BioStor Sytems, Inc.
  • Marken（UPS Company）
  • DHL
  • FedEx
  • Thermo Fisher Scientific Inc.
  • Yourway
  • A.P. Moller-Maersk
  • Atelerix Ltd.
  • Nordic Cold Chain Solutions
  • MasterControl Solutions, Inc.
  • TrakCel
  • Modality Solutions
  • SedApta s.r.l.

第16章 總結/建議

  • Visiongain的總結
  • 對進入市場的公司的建議
Product Code: PHA1345

The global Cell and Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15.5% by 2034

The Cell and Gene Therapy Cold Chain Logistics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

High Cancer Prevalence is Propelling the Adoption of Cell and Gene Therapies

The global incidence of cancer has been rising steadily over the past decade, significantly influencing the adoption of advanced treatments like cell and gene therapies. This increase includes various cancers such as lymphoma, leukemia, myeloma, and melanoma, which affect critical bodily systems including the lymphatic system, lymph nodes, bone marrow, and blood cells. PAHO/WHO reported that in 2023, there were around 20 million new cancer cases. Projections indicate a notable increase in the global cancer burden, with over 28 million new cases expected by 2040. In the U.S., Non-Hodgkin lymphoma alone accounts for more than 4% of all cancer cases, making it one of the most prevalent types. These statistics underscore the urgent need for innovative treatments. Cell and gene therapies, which have shown remarkable success and received regulatory approval, are increasingly seen as vital to addressing the unmet medical needs of cancer patients worldwide.

Inadequate Infrastructure for Cold Chain Logistics in Developing Nations Likely to Challenge Industry Growth

Access to cell and gene therapies in developing and remote regions is significantly restricted by inadequate cold chain logistics infrastructure. The reliability of refrigeration is often compromised by inconsistent power supplies, leading to a heightened risk of product spoilage. Transportation infrastructure in these regions also poses a major challenge, complicating the timely delivery of therapies and resulting in delays. Overcoming these logistical barriers requires strategic partnerships with local logistics providers, such as Riders for Health in Africa, to ensure effective distribution networks.

Furthermore, the shortage of trained personnel in cold chain management exacerbates these issues, emphasizing the need for specialized training programs. Collaborations between global organizations like the WHO and local authorities are essential to enhancing cold chain logistics capabilities. Such partnerships can significantly improve the infrastructure needed to support the widespread availability of cell and gene therapies, ultimately expanding access to these critical treatments in underserved regions.

What Questions Should You Ask before Buying a Market Research Report?

How is the cell and gene therapy cold chain logistics market evolving?

What is driving and restraining the cell and gene therapy cold chain logistics market?

How will each cell and gene therapy cold chain logistics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each cell and gene therapy cold chain logistics submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading cell and gene therapy cold chain logistics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the cell and gene therapy cold chain logistics projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of cell and gene therapy cold chain logistics projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the cell and gene therapy cold chain logistics market?

Where is the cell and gene therapy cold chain logistics market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell and gene therapy cold chain logistics market today, and over the next 10 years:

Our 359-page report provides 146 tables and 198 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.

Segments Covered in the Report

Component

Cryogenic Shippers

Cryogenic Storage Freezers

Ultra-Low Freezers

Cold Chain Management Systems

Shipment and Storage Medium

Cryogenic Packout Kits

Others

Services

Transportation

Storage

Packaging

Mode of Transport

Air Transport

Ground Transport

Water Transport

Holding Temperature Range

Cryogenic

Refrigerated

Ambient

Others

End-users

Biopharmaceutical and Biotechnology Companies

Academic & Research Institutes

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Switzerland

Belgium

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Singapore

Malaysia

Thailand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles for some of the leading companies in the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

A.P. Moller - Maersk

Arvato SE

Atelerix Ltd.

BioLife Solutions Inc.

BioStor Sytems Inc.

Cardinal Health

Catalent Inc.

Cencora, Inc.

CryoPort Inc.

DHL

FedEx

Marken (a UPS Company)

MasterControl Solutions, Inc.

Modality Solutions

NMDP BioTherapies

Nordic Cold Chain Solutions

sedApta s.r.l.

Polar Express Transportation

Thermo Fisher Scientific Inc.

TrakCel

Yourway

Overall world revenue for Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 in terms of value the market will surpass US$1,800 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 report help you?

In summary, our 350+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, with forecasts for component, services, mode of transport, holding temperature range, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 23 key national markets - See forecasts for the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Switzerland, Belgium, Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Brazil, Mexico, Argentina, GCC, and South Africa among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 21 of the major companies involved in the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Cell and Gene Therapy Cold Chain Logistics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Advancements in Storage and Transportation of Biologics
      • 3.3.1.2 Increasing Adoption of Gene and Cell Therapies
      • 3.3.1.3 High Prevalence of Cancer and Genetic Disorders
      • 3.3.1.4 Increasing Strategic Initiatives Among Market Players
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 High Cost of Cell and Gene Therapy Storage and Transportation
      • 3.3.2.2 Absence of Adequate Infrastructure for Cold Chain Logistics in Developing Nations
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Strong Clinical Pipeline and Increasing Approval for Cell and Gene Therapy Products
      • 3.3.3.2 Lucrative Opportunities in Developing Countries
      • 3.3.3.3 Stringent Government Regulations for Cell & Gene Therapy
      • 3.3.3.4 Favourable Initiatives and Programs for Easier Access to Cell and Gene Therapy
  • 3.4 Regulatory Framework
  • 3.5 Emerging Markets and Megatrends
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 Bargaining Power of Suppliers
    • 3.6.2 Bargaining Power of Buyers
    • 3.6.3 Competitive Rivalry
    • 3.6.4 Threat from Substitutes
    • 3.6.5 Threat of New Entrants
  • 3.7 PEST Analysis

4 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Components

  • 4.1 Key Findings
  • 4.2 Components Segment: Market Attractiveness Index
  • 4.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 4.4 Cryogenic Shippers
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Cryogenic Storage Freezers
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Ultra-Low Freezers
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Cold Chain Management Systems
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Shipment and Storage Medium
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Cryogenic Packout Kits
    • 4.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Others
    • 4.10.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)

5 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Services

  • 5.1 Key Findings
  • 5.2 Services Segment: Market Attractiveness Index
  • 5.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 5.4 Transportation
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Storage
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Packaging
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Mode of Transport

  • 6.1 Key Findings
  • 6.2 Mode of Transport Segment: Market Attractiveness Index
  • 6.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 6.4 Air Transport
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Ground Transport
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Water Transport
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Holding Temperature

  • 7.1 Key Findings
  • 7.2 Holding Temperature Segment: Market Attractiveness Index
  • 7.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 7.4 Cryogenic
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Refrigerated
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Ambient
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Others
    • 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.7.2 Market Share by Region, 2024 & 2034 (%)

8 Cell and Gene Therapy Cold Chain Logistics Market Analysis by End-users

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-User
  • 8.4 Biopharmaceutical and Biotechnology Companies
    • 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 Academic & Research Institutes
    • 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Others
    • 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)

9 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 10.3 North America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 10.5 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 10.6 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 10.7 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 10.8 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 10.9 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 10.10 U.S. Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 10.11 Canada Cell and Gene Therapy Cold Chain Logistics Market Analysis

11 Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 11.3 Europe Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 11.5 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 11.6 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 11.7 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 11.8 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 11.9 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 11.10 Germany Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.11 UK Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.12 France Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.13 Italy Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.14 Spain Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.15 Russia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.16 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.17 Belgium Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.18 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis

12 Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 12.3 Asia Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 12.5 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 12.6 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 12.7 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 12.8 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 12.9 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 12.10 Japan Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.11 China Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.12 India Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.13 Australia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.14 South Korea Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.15 Singapore Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.16 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.17 Thailand Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.18 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis

13 Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 13.3 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 13.5 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 13.6 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 13.7 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 13.8 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 13.9 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 13.10 Brazil Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.11 Mexico Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.12 Argentina Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.13 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis

14 MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 14.3 MEA Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 14.4 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 14.5 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 14.6 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 14.7 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 14.8 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 14.9 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 14.10 GCC Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 14.11 South Africa Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 14.12 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis

15 Company Profiles

  • 15.1 Company Share Analysis, 2023
  • 15.2 Strategic Outlook
  • 15.3 Cencora, Inc.
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2019-2023
      • 15.3.3.2 Regional Market Shares, 2023
    • 15.3.4 Service Benchmarking
    • 15.3.5 Strategic Outlook
    • 15.3.6 SWOT Analysis
  • 15.4 Arvato SE
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Service Benchmarking
    • 15.4.4 Strategic Outlook
  • 15.5 Polar Express Transportation
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Service Benchmarking
  • 15.6 NMDP BioTherapies
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Service Benchmarking
    • 15.6.4 Strategic Outlook
  • 15.7 BioLife Solutions, Inc.
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2019-2023
      • 15.7.3.2 R&D, 2019-2023
      • 15.7.3.3 Segment Market Shares, 2023
    • 15.7.4 Service Benchmarking
    • 15.7.5 Strategic Outlook
    • 15.7.6 SWOT Analysis
  • 15.8 Cardinal Health
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2019-2023
      • 15.8.3.2 Regional Market Shares, 2023
      • 15.8.3.3 Segment Market Shares, 2023
    • 15.8.4 Service Benchmarking
    • 15.8.5 Strategic Outlook
    • 15.8.6 SWOT Analysis
  • 15.9 Catalent, Inc.
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2019-2023
      • 15.9.3.2 Regional Market Shares, 2023
      • 15.9.3.3 Segment Market Shares, 2023
    • 15.9.4 Service Benchmarking
    • 15.9.5 Strategic Outlook
    • 15.9.6 SWOT Analysis
  • 15.10 Cryoport Inc.
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2019-2023
      • 15.10.3.2 Regional Market Shares, 2023
      • 15.10.3.3 Segment Market Shares, 2023
    • 15.10.4 Service Benchmarking
    • 15.10.5 Strategic Outlook
    • 15.10.6 SWOT Analysis
  • 15.11 BioStor Sytems, Inc.
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Service Benchmarking
  • 15.12 Marken (a UPS Company)
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Service Benchmarking
    • 15.12.4 Strategic Outlook
    • 15.12.5 SWOT Analysis
  • 15.13 DHL
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Service Benchmarking
    • 15.13.4 Financial Analysis
      • 15.13.4.1 Net Revenue, 2019-2023
      • 15.13.4.2 Regional Market Shares, 2023
      • 15.13.4.3 Segment Market Shares, 2023
    • 15.13.5 Strategic Outlook
    • 15.13.6 SWOT Analysis
  • 15.14 FedEx
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Service Benchmarking
    • 15.14.4 Financial Analysis
      • 15.14.4.1 Net Revenue, 2019-2023
      • 15.14.4.2 Regional Market Shares, 2023
    • 15.14.5 Strategic Outlook
    • 15.14.6 SWOT Analysis
  • 15.15 Thermo Fisher Scientific Inc.
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Service Benchmarking
    • 15.15.4 Strategic Outlook
  • 15.16 Yourway
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Service Benchmarking
    • 15.16.4 Strategic Outlook
  • 15.17 A.P. Moller - Maersk
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2019-2023
      • 15.17.3.2 Regional Market Shares, 2023
      • 15.17.3.3 Segment Market Shares, 2023
    • 15.17.4 Service Benchmarking
    • 15.17.5 Strategic Outlook
    • 15.17.6 SWOT Analysis
  • 15.18 Atelerix Ltd.
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Service Benchmarking
    • 15.18.4 Strategic Outlook
  • 15.19 Nordic Cold Chain Solutions
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Service Benchmarking
    • 15.19.4 Strategic Outlook
  • 15.20 MasterControl Solutions, Inc.
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Service Benchmarking
  • 15.21 TrakCel
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Service Benchmarking
    • 15.21.4 Strategic Outlook
  • 15.22 Modality Solutions
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Service Benchmarking
  • 15.23 SedApta s.r.l.
    • 15.23.1 Company Snapshot
    • 15.23.2 Company Overview
    • 15.23.3 Service Benchmarking
    • 15.23.4 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players

List of Tables

  • Table 1 Cell and Gene Therapy Cold Chain Logistics Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Major FDA Approved Cell and Gene Therapies
  • Table 3 Clinical Pipeline: Major Cell and Gene Therapies
  • Table 4 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 5 Cryogenic Shippers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 6 Cryogenic Storage Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Ultra-Low Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Cold Chain Management Systems Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Shipment and Storage Medium Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 Cryogenic Packout Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Transportation Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Storage Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Packaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Air Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Ground Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Water Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Cryogenic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Refrigerated Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Ambient Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Brazil Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 Mexico Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 76 Argentina Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 77 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 78 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 79 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 80 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 81 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 82 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 83 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 84 GCC Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 85 South Africa Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 86 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 87 Strategic Outlook
  • Table 88 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Cencora, Inc.: Service Benchmarking
  • Table 90 Cencora, Inc: Strategic Outlook
  • Table 91 Arvato SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Arvato SE: Service Benchmarking
  • Table 93 Arvato SE Strategic Outlook
  • Table 94 Polar Express Transportation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Polar Express Transportation: Service Benchmarking
  • Table 96 NMDP BioTherapies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 NMDP BioTherapies: Service Benchmarking
  • Table 98 NMDP BioTherapies Strategic Outlook
  • Table 99 BioLife Solution Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 BioLife Solution Inc.: Service Benchmarking
  • Table 101 BioLife Solution Inc. Strategic Outlook
  • Table 102 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Cardinal Health: Service Benchmarking
  • Table 104 Cardinal Health: Strategic Outlook
  • Table 105 Catalent Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Catalent Inc.: Service Benchmarking
  • Table 107 Catalent Inc. Strategic Outlook
  • Table 108 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Cryoport Inc.: Service Benchmarking
  • Table 110 Cryoport Strategic Outlook
  • Table 111 BioStor Sytems, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 BioStor Sytems, Inc.: Service Benchmarking
  • Table 113 Marken (a UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Marken (a UPS Company): Service Benchmarking
  • Table 115 Marken (a UPS Company) Strategic Outlook
  • Table 116 DHL: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 DHL: Service Benchmarking
  • Table 118 DHL: Strategic Outlook
  • Table 119 FedEx : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 FedEx : Service Benchmarking
  • Table 121 FedEx : Strategic Outlook
  • Table 122 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 124 Thermo Fisher Scientific Inc. Strategic Outlook
  • Table 125 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 126 Yourway: Service Benchmarking
  • Table 127 Yourway: Strategic Outlook
  • Table 128 A.P. Moller - Maersk: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 A.P. Moller - Maersk: Service Benchmarking
  • Table 130 A.P. Moller - Maersk: Strategic Outlook
  • Table 131 Atelerix Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 132 Atelerix Ltd: Service Benchmarking
  • Table 133 Atelerix Ltd: Strategic Outlook
  • Table 134 Nordic Cold Chain Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 Nordic Cold Chain Solutions: Service Benchmarking
  • Table 136 Nordic Cold Chain Solutions: Strategic Outlook
  • Table 137 MasterControl Solutions, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 MasterControl Solutions, Inc.: Service Benchmarking
  • Table 139 TrakCel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 140 TrakCel: Service Benchmarking
  • Table 141 TrakCel: Strategic Outlook
  • Table 142 Modality Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 143 Modality Solutions: Service Benchmarking
  • Table 144 sedApta s.r.l.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 sedApta s.r.l.: Service Benchmarking
  • Table 146 sedApta s.r.l.: Strategic Outlook

List of Figures

  • Figure 1 Cell and Gene Therapy Cold Chain Logistics Market Segmentation
  • Figure 2 Cell and Gene Therapy Cold Chain Logistics Market by Component: Market Attractiveness Index
  • Figure 3 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Services
  • Figure 4 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Mode of Transport
  • Figure 5 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Holding Temperature Range
  • Figure 6 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by End-user
  • Figure 7 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Region
  • Figure 8 Cell and Gene Therapy Cold Chain Logistics Market: Market Dynamics
  • Figure 9 Cell and Gene Therapy Cold Chain Logistics Market: Impact Analysis
  • Figure 10 Cell and Gene Therapy Cold Chain Logistics Market: Porter's Five Forces Analysis
  • Figure 11 Cell and Gene Therapy Cold Chain Logistics Market: PEST Analysis
  • Figure 12 Cell and Gene Therapy Cold Chain Logistics Market by Components: Market Attractiveness Index
  • Figure 13 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 14 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Components, 2024, 2029, 2034 (%)
  • Figure 15 Cryogenic Shippers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 16 Cryogenic Shippers Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 Cryogenic Storage Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 18 Cryogenic Storage Freezers Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Ultra-Low Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 20 Ultra-Low Freezers Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Cold Chain Management Systems Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 22 Cold Chain Management Systems Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Shipment and Storage Medium Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 24 Shipment and Storage Medium Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Cryogenic Packout Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 26 Cryogenic Packout Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Cell and Gene Therapy Cold Chain Logistics Market by Services: Market Attractiveness Index
  • Figure 30 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 31 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Services, 2024, 2029, 2034 (%)
  • Figure 32 Transportation Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 33 Transportation Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Storage Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Storage Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Packaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 37 Packaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transport: Market Attractiveness Index
  • Figure 39 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 40 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Mode of Transport, 2024, 2029, 2034 (%)
  • Figure 41 Air Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 42 Air Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Ground Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Ground Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Water Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 46 Water Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature: Market Attractiveness Index
  • Figure 48 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 49 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Holding Temperature, 2024, 2029, 2034 (%)
  • Figure 50 Cryogenic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 51 Cryogenic Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 Refrigerated Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 53 Refrigerated Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Ambient Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 55 Ambient Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 57 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 58 Cell and Gene Therapy Cold Chain Logistics Market by End-users: Market Attractiveness Index
  • Figure 59 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 60 Cell And Gene Therapy Cold Chain Logistics Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 61 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 62 Biopharmaceutical and Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 63 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 64 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 65 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 66 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 67 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 68 Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 69 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 70 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 71 North America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 72 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 73 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 74 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 75 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
  • Figure 76 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 77 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
  • Figure 78 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 79 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
  • Figure 80 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 81 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
  • Figure 82 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 83 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 84 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 85 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 86 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 87 Europe Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 88 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 89 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 90 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 91 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
  • Figure 92 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 93 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
  • Figure 94 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 95 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
  • Figure 96 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 97 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
  • Figure 98 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 100 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 102 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 103 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 104 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 106 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 107 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 108 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 110 Asia Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 111 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 112 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 113 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 114 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
  • Figure 115 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 116 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
  • Figure 117 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 118 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
  • Figure 119 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 120 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
  • Figure 121 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 123 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 124 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 125 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 126 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 127 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 128 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 129 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 130 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 131 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 132 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 133 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 134 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 135 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 136 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 137 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
  • Figure 138 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 139 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
  • Figure 140 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 141 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
  • Figure 142 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 143 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
  • Figure 144 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 145 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 146 Brazil Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 147 Mexico Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 148 Argentina Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 149 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 150 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 151 MEA Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 152 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 153 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 154 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
  • Figure 155 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
  • Figure 156 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
  • Figure 157 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
  • Figure 158 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
  • Figure 159 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
  • Figure 160 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
  • Figure 161 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
  • Figure 162 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 163 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 164 GCC Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 165 South Africa Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 166 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 167 Cell and Gene Therapy Cold Chain Logistics Market: Company Share Analysis, 2023
  • Figure 168 Cencora, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
  • Figure 169 Cencora, Inc.: Regional Market Shares, 2023
  • Figure 170 Cencora, Inc.: SWOT Analysis
  • Figure 171 BioLife Solution Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
  • Figure 172 BioLife Solution Inc.: R&D, 2019-2023 (US$ Million, AGR%)
  • Figure 173 BioLife Solution Inc: Business Segment Market Shares, 2023
  • Figure 174 BioLife Solution Inc.: SWOT Analysis
  • Figure 175 Cardinal Health: Net Revenue,